Results 241 to 250 of about 2,650,230 (376)
ARID1A, a SWI/SNF complex component, is frequently mutated in colorectal cancer (CRC). CRC with ARID1A/TP53 concurrent mutations shows marked sensitivity to WEE1 inhibition. ARID1A loss induces R‐loop‐mediated replication stress, impairs ATF3 transcription, and amplifies WEE1i‐induced DNA damage, suggesting a promising therapeutic vulnerability ...
Chi Zhang +17 more
wiley +1 more source
Osteosarcoma is the most common primary bone tumor with limited treatment options and a terrible prognosis. This review provides a comprehensive summary of the recent development of osteoimmunomodulatory implants for post‐operative osteosarcoma treatment, of which the potential utility in evoking durable anti‐osteosarcoma immunity and accelerating bone
Yilong Dong +6 more
wiley +1 more source
The purinergic signaling interfaces in breast cancer angiogenesis. [PDF]
da Silva FC +3 more
europepmc +1 more source
Modeling and Simulation of VEGF Receptors Recruitment in Angiogenesis [PDF]
A. Salvadori +3 more
openalex +1 more source
A post‐stroke perivascular niche of microglia characterized by low expression of M2 markers and elevated glycolysis, oxidative phosphorylation (OXPHOS), and phagocytic activity is identified, which is termed stroke‐activated vascular‐associated microglia (stroke‐VAM).
Yanan Li +8 more
wiley +1 more source
Prolonged blockade of VEGF receptors does not damage retinal photoreceptors or ganglion cells
A. Miki +9 more
semanticscholar +1 more source
This study provides the first evidence that PM2.5 impairs iWAT browning via PTG‐mediated glycogen metabolism disruption, which is initiated by ADRB3 inhibition and subsequently triggers VEGFB upregulation. It thereby delineates the ADRB3‐PTG‐VEGFB axis as central to PM2.5‐induced metabolic dysfunction and identifies adipose glycogen metabolism as a ...
Limin Wang +12 more
wiley +1 more source
A cytokine receptor-targeting chimera toolbox for expanding extracellular targeted protein degradation. [PDF]
Kumru K +8 more
europepmc +1 more source
Discovery of pan-VEGF inhibitory peptides directed to the extracellular ligand-binding domains of the VEGF receptors. [PDF]
Michaloski JS +4 more
europepmc +1 more source
A. Jebreel +5 more
semanticscholar +1 more source

